P. Goss

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

T. Schnitzer, A. Laupacis, P. Tugwell, 2013, BDJ.

International Symposium on Signal Transduction in Health and Disease on Neuroendocrinology: Basic and Clinical Aspects

J. Hopper, P. Goss, N. Mauras, 2008 .

New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17.

P. Goss, D. Tu, K. Pritchard, 2016, Breast.

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

X. Y. Zhang, T. Schnitzer, A. Laupacis, 2013, BDJ.

Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study.

P. Goss, C. Tsalamandris, E. Seeman, 1996, The American journal of physiology.

Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen.

T. Whelan, S. Martino, N. Robert, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial

P. Goss, P. Goss, J. Pater, 2007, Current oncology.

3 trial : an international breast cancer prevention trial

P. Goss, H. Richardson, J. Pater, 2007 .

NCIC CTG MA.17: Intent to treat analysis (ITT) of randomized patients after a median follow-up of 54 months.

P. Goss, J. Ingle, D. Tu, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.